Globus Medical Historical PE Ratio image   This GMED PE ratio history page last updated 3/11/2024
Globus Medical Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
2/20/2024
54.160.602.4022.6
Q3 2023
11/7/2023
46.190.572.2820.3
Q2 2023
8/3/2023
57.790.632.5222.9
Q1 2023
5/4/2023
56.590.532.1226.7
Q4 2022
2/21/2023
59.130.592.3625.1
Q3 2022
11/8/2022
64.290.502.0032.1
Q2 2022
8/4/2022
58.850.562.2426.3
Q1 2022
5/10/2022
61.220.421.6836.4
Q4 2021
2/17/2022
66.340.491.9633.8
Q3 2021
11/4/2021
77.350.502.0038.7
Q2 2021
8/4/2021
80.630.562.2436.0
Q1 2021
5/4/2021
69.640.491.9635.5
Q4 2020
2/17/2021
66.720.582.3228.8
Q3 2020
10/28/2020
49.620.491.9625.3
Q2 2020
8/5/2020
50.660.070.28180.9
Q1 2020
5/7/2020
47.800.291.1641.2
Q4 2019
2/20/2020
56.450.491.9628.8
Q3 2019
11/6/2019
53.060.431.7230.8
Q2 2019
8/1/2019
46.390.411.6428.3
Q1 2019
5/2/2019
45.960.361.4431.9
Q4 2018
2/21/2019
47.690.431.7227.7
Q3 2018
11/8/2018
57.440.391.5636.8
Q2 2018
8/1/2018
52.850.441.7630.0
Q1 2018
5/2/2018
49.650.411.6430.3
Q4 2017
2/21/2018
48.000.381.5231.6
Q3 2017
11/8/2017
31.840.301.2026.5
Q2 2017
8/2/2017
30.560.321.2823.9
Q1 2017
5/3/2017
30.560.321.2823.9
Q4 2016
2/27/2017
28.610.311.2423.1
Q3 2016
11/8/2016
22.330.291.1619.2
Q2 2016
7/26/2016
26.430.291.1622.8
Q1 2016
5/3/2016
24.980.291.1621.5
Q4 2015
2/24/2016
23.740.321.2818.5
Q3 2015
11/3/2015
23.260.281.1220.8
Q2 2015
7/30/2015
27.850.251.0027.9
Q1 2015
5/5/2015
23.510.261.0422.6
Q4 2014
2/25/2015
25.010.301.2020.8
Q3 2014
10/30/2014
20.900.240.9621.8
Q2 2014
8/5/2014
22.560.230.9224.5
Q1 2014
4/29/2014
22.750.240.9623.7
Q4 2013
2/26/2014
24.150.251.0024.1
Q3 2013
10/30/2013
17.900.220.8820.3
Q2 2013
8/1/2013
16.750.210.8419.9
Q1 2013
5/2/2013
15.680.210.8418.7
Q4 2012
2/27/2013
13.820.220.8815.7
Q3 2012
11/1/2012
17.670.180.7224.5
Q2 2012
8/21/2012
14.220.210.8416.9
Q1 2012
5/1/2012
NA0.190.76NA
Globus Medical PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
2/20/2024
54.160.602.3323.2
Q3 2023
11/7/2023
46.190.572.3219.9
Q2 2023
8/3/2023
57.790.632.2525.7
Q1 2023
5/4/2023
56.590.532.1826.0
Q4 2022
2/21/2023
59.130.592.0728.6
Q3 2022
11/8/2022
64.290.501.9732.6
Q2 2022
8/4/2022
58.850.561.9729.9
Q1 2022
5/10/2022
61.220.421.9731.1
Q4 2021
2/17/2022
66.340.492.0432.5
Q3 2021
11/4/2021
77.350.502.1336.3
Q2 2021
8/4/2021
80.630.562.1238.0
Q1 2021
5/4/2021
69.640.491.6342.7
Q4 2020
2/17/2021
66.720.581.4346.7
Q3 2020
10/28/2020
49.620.491.3437.0
Q2 2020
8/5/2020
50.660.071.2839.6
Q1 2020
5/7/2020
47.800.291.6229.5
Q4 2019
2/20/2020
56.450.491.6933.4
Q3 2019
11/6/2019
53.060.431.6332.6
Q2 2019
8/1/2019
46.390.411.5929.2
Q1 2019
5/2/2019
45.960.361.6228.4
Q4 2018
2/21/2019
47.690.431.6728.6
Q3 2018
11/8/2018
57.440.391.6235.5
Q2 2018
8/1/2018
52.850.441.5334.5
Q1 2018
5/2/2018
49.650.411.4135.2
Q4 2017
2/21/2018
48.000.381.3236.4
Q3 2017
11/8/2017
31.840.301.2525.5
Q2 2017
8/2/2017
30.560.321.2424.6
Q1 2017
5/3/2017
30.560.321.2125.3
Q4 2016
2/27/2017
28.610.311.1824.2
Q3 2016
11/8/2016
22.330.291.1918.8
Q2 2016
7/26/2016
26.430.291.1822.4
Q1 2016
5/3/2016
24.980.291.1421.9
Q4 2015
2/24/2016
23.740.321.1121.4
Q3 2015
11/3/2015
23.260.281.0921.3
Q2 2015
7/30/2015
27.850.251.0526.5
Q1 2015
5/5/2015
23.510.261.0322.8
Q4 2014
2/25/2015
25.010.301.0124.8
Q3 2014
10/30/2014
20.900.240.9621.8
Q2 2014
8/5/2014
22.560.230.9424.0
Q1 2014
4/29/2014
22.750.240.9224.7
Q4 2013
2/26/2014
24.150.250.8927.1
Q3 2013
10/30/2013
17.900.220.8620.8
Q2 2013
8/1/2013
16.750.210.8220.4
Q1 2013
5/2/2013
15.680.210.8219.1
Q4 2012
2/27/2013
13.820.220.8017.3
Q3 2012
11/1/2012
17.670.18NANA
Q2 2012
8/21/2012
14.220.21NANA
Q1 2012
5/1/2012
NA0.19NANA
Quotes delayed 20 minutes

Email EnvelopeFree GMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Globus Medical (GMED) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

GMTX PE Ratio History
GNCA PE Ratio History
GNLX PE Ratio History
GNPX PE Ratio History
GOSS PE Ratio History
GOVX PE Ratio History
GRAY PE Ratio History
GRPH PE Ratio History
GRTS PE Ratio History
GRTX PE Ratio History
How should the GMED historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Globus Medical. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this GMED Historical PE Ratio page.

What is the average historical PE for GMED based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The GMED historical PE ratio using the annualized quarterly earnings method works out to 29.6.

What is the average historical PE for GMED based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The GMED historical PE ratio using the TTM earnings method works out to 28.2.

What is the average historical PE for GMED based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The GMED historical PE ratio using the annualized median TTM earnings method works out to 2.32.

On this page we presented the Globus Medical Historical PE Ratio information for Globus Medical' stock. The average GMED historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 29.6. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average GMED historical PE based on this TTM earnings result method is 28.2.

Let's now compare this GMED historical PE result, against the recent PE: when this page was posted on 3/8/2024, the most recent closing price for GMED had been 55.36, and the most recent quarterly earnings result, annualized, was 2.4. Meanwhile, the most recent TTM earnings summed to 2.33. From these numbers, we calculate the recent GMED PE on 3/8/2024 based on annualized quarterly EPS was 23.1. Based on GMED's history, that recent PE is low relative to the historical average, with the recent PE 22.0% lower than the historical average PE across our data set for Globus Medical. Looking at the recent GMED PE on 3/8/2024 based on TTM EPS, we calculate the ratio at 23.8. Based on GMED's history, that recent PE is low relative to the historical average, with the recent PE 15.6% lower than the average PE across our Globus Medical data set with TTM EPS used in the calculation at each period.

Another interesting GMED historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for GMED, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for GMED, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.53, 0.57, 0.60, and 0.63. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.57 and 0.60 — which gives us the median of 0.58. Basically the way to think about this 0.58 number is this: for the trailing four earnings reports, 0.58 marks the "middle ground" number where GMED has reported a value higher than 0.58 half the time, and has reported a value lower than 0.58 half the time. Annualizing that median value then gets us to 2.32/share, which we use as the denominator in our next PE calculation. With 55.36 as the numerator (as of 3/8/2024), the calculation is then 55.36 / 2.32 = 23.9 as the GMED PE ratio as of 3/8/2024, based on that annualized median value we calculated.

For self directed investors doing their due diligence on GMED or any other given stock, valuation analysis for GMED can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Globus Medical PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for GMED. Thanks for visiting, and the next time you need to research GMED Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of CLDB, CCH Videos, SPTL Options Chain.

 

Globus Medical Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.